Plain-English translation of NCT06235151 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new imaging scan called PET/CT that may help doctors see prostate cancer more clearly before surgery. The scan uses a small amount of radioactive tracer injected into your bloodstream to create detailed pictures of your body. Researchers want to know if this new imaging method can accurately detect cancer that may have spread to lymph nodes or other parts of your body.
Current imaging methods don't always catch all the cancer before surgery, which can affect treatment planning and outcomes. This trial is testing whether the new medication can provide clearer pictures and help doctors find cancer spread that might otherwise be missed.
If you qualify, you will receive an injection of the imaging medication and then have a PET/CT scan about 1 to 4 hours later. The scan takes pictures to help doctors see if cancer has spread. Three independent radiologists will review your images to determine if the new imaging method accurately detects cancer. Your actual surgery and pathology results will then be compared to the scan results to measure how well the new imaging worked.
AI-generated summary from trial data · Aug 20, 2026 · Not medical advice
United States